Total Revenues of $610.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $555.0 million -- GAAP Diluted EPS of $0.79, Non-GAAP Diluted EPS of $0.87 -- Announced Additional Stock ...
Should patients with operable pancreatic cancer go straight to surgery or receive systemic therapy first? While surgical resection remains the only potentially curative option for pancreatic ductal ...
A Mansfield man's routine health screenings eventually uncovered cancer, but advanced robotic technology at Mount Carmel St.
Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...
Molecular/genomic profiling is expanding precision selection of systemic therapy and may enable immunotherapy-driven organ ...
Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term follow-up care strategies.
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...
Prostate cancer represents one of the most common malignancies in men in developed countries with increasing incidence in recent years due to the ...
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...
Earnings Driven by Focused Execution and 22% Op Revenue Growth of Launched and Acquired Products(1)Pipeline Momentum Builds on Positive Phase 3 and Mid-Stage ReadoutsRobust Late‑Stage R&D Pipeline, On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results